Andrew Mc Closkey

PhoneUNKNOWN

Cromore Road, Coleraine Campus
BT52 1SA Coleraine
United Kingdom

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Andrew Mc Closkey is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

18 Citations - Sourced from Scopus
3 h-Index - Sourced from Scopus
3 Article
1 Review article

A long-acting, dual-agonist analogue of lamprey GLP-1 shows potent insulinotropic, β-cell protective, and anorexic activities and improves glucose homeostasis in high fat-fed mice
Graham, G., Mc Closkey, A., Abdel-Wahab, Y., Conlon, JM. & Flatt, PR., 1 Jan 2020, In: Molecular and Cellular Endocrinology. 499, 110584.
Research output: Contribution to journal › Article › peer-review

Open Access
File
3 Citations (Scopus)

27 Downloads (Pure)
CRISPR/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function
McCloskey, A. G., Miskelly, M. G., Moore, T. C. B., Nesbit, M. A., Christie, K., Owolabi, A., Flatt, PR. & McKillop, A., 31 Mar 2020, In: Peptides. 125, p. 1-8 8 p., 170251.
Research output: Contribution to journal › Review article › peer-review

Open Access
File
5 Citations (Scopus)

3 Downloads (Pure)
Peptide YY (1–36) peptides from phylogenetically ancient fish targeting mammalian neuropeptide Y1 receptors demonstrate potent effects on pancreatic β-cell function, growth and survival
Lafferty, R., Tanday, N., Mc Closkey, A., Bompada, P., De Marinis, Y., Flatt, PR. & Irwin, N., 31 Mar 2020, In: Diabetes, Obesity and Metabolism. 22, 3, p. 404-416 13 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
7 Citations (Scopus)

13 Downloads (Pure)
Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis
Mc Closkey, A., Miskelly, M., Flatt, PR. & McKillop, A., 15 Jan 2020, In: European Journal of Pharmaceutical Sciences. 142, 10 p., 105104.
Research output: Contribution to journal › Article › peer-review

Open Access
File
3 Citations (Scopus)

17 Downloads (Pure)

Evaluation of GPR55 and GPR120 as novel therapeutic targets for the treatment of type 2 diabetes
Author: Mc Closkey, A., May 2019
Supervisor: Flatt, P. (Supervisor) & McKillop, A. (Supervisor)
Student thesis: Doctoral Thesis

File

A long-acting, dual-agonist analogue of lamprey GLP-1 shows potent insulinotropic, β-cell protective, and anorexic activities and improves glucose homeostasis in high fat-fed mice

CRISPR/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function

Peptide YY (1–36) peptides from phylogenetically ancient fish targeting mammalian neuropeptide Y1 receptors demonstrate potent effects on pancreatic β-cell function, growth and survival

Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis

Evaluation of GPR55 and GPR120 as novel therapeutic targets for the treatment of type 2 diabetes